| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.31 | 0.08 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |